381 related articles for article (PubMed ID: 1394140)
1. Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251.
Andrejauskas-Buchdunger E; Regenass U
Cancer Res; 1992 Oct; 52(19):5353-8. PubMed ID: 1394140
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Druker BJ; Lydon NB
Cancer Res; 1996 Jan; 56(1):100-4. PubMed ID: 8548747
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
5. Activation of signal transduction pathways protects quiescent Balb/c-3T3 fibroblasts against death due to serum deprivation.
Tamm I; Kikuchi T
J Cell Physiol; 1991 Jul; 148(1):85-95. PubMed ID: 1713593
[TBL] [Abstract][Full Text] [Related]
6. Inhibition or down-regulation of protein kinase C attenuates late phase p70s6k activation induced by epidermal growth factor but not by platelet-derived growth factor or insulin.
Susa M; Vulević D; Lane HA; Thomas G
J Biol Chem; 1992 Apr; 267(10):6905-9. PubMed ID: 1551899
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
8. Interferons block protein kinase C-dependent but not-independent activation of Raf-1 and mitogen-activated protein kinases and mitogenesis in NIH 3T3 cells.
Xu J; Rockow S; Kim S; Xiong W; Li W
Mol Cell Biol; 1994 Dec; 14(12):8018-27. PubMed ID: 7526152
[TBL] [Abstract][Full Text] [Related]
9. The protein kinase A pathway inhibits c-jun and c-fos protooncogene expression induced by the protein kinase C and tyrosine kinase pathways in cultured human thyroid follicles.
Heinrich R; Kraiem Z
J Clin Endocrinol Metab; 1997 Jun; 82(6):1839-44. PubMed ID: 9177393
[TBL] [Abstract][Full Text] [Related]
10. Two signal transduction pathways mediate interleukin-1 receptor expression in Balb/c3T3 fibroblasts.
Bonin PD; Chiou WJ; McGee JE; Singh JP
J Biol Chem; 1990 Oct; 265(30):18643-9. PubMed ID: 2170417
[TBL] [Abstract][Full Text] [Related]
11. Preferential inhibition of the platelet-derived growth factor receptor tyrosine kinase by staurosporine.
Secrist JP; Sehgal I; Powis G; Abraham RT
J Biol Chem; 1990 Nov; 265(33):20394-400. PubMed ID: 2173705
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.
Yagi M; Kato S; Kobayashi Y; Kubo K; Oyama S; Shimizu T; Nishitoba T; Isoe T; Nakamura K; Ohashi H; Kobayashi N; Iinuma N; Osawa T; Onose R; Osada H
Exp Cell Res; 1997 Aug; 234(2):285-92. PubMed ID: 9260896
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.
Begemann M; Kashimawo SA; Choi YA; Kim S; Christiansen KM; Duigou G; Mueller M; Schieren I; Ghosh S; Fabbro D; Lampen NM; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
Clin Cancer Res; 1996 Jun; 2(6):1017-30. PubMed ID: 9816263
[TBL] [Abstract][Full Text] [Related]
15. Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells.
Tripathi YB; Lim RW; Fernandez-Gallardo S; Kandala JC; Guntaka RV; Shukla SD
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):527-33. PubMed ID: 1382409
[TBL] [Abstract][Full Text] [Related]
16. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity.
Meyer T; Regenass U; Fabbro D; Alteri E; Rösel J; Müller M; Caravatti G; Matter A
Int J Cancer; 1989 May; 43(5):851-6. PubMed ID: 2714889
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of early gene expression by angiotensin II in bovine adrenal glomerulosa cells: roles of calcium and protein kinase C.
Clark AJ; Balla T; Jones MR; Catt KJ
Mol Endocrinol; 1992 Nov; 6(11):1889-98. PubMed ID: 1336125
[TBL] [Abstract][Full Text] [Related]
18. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro.
Dlugosz AA; Yuspa SH
Cancer Res; 1991 Sep; 51(17):4677-84. PubMed ID: 1678684
[TBL] [Abstract][Full Text] [Related]
19. BALB/c-3T3 fibroblasts resistant to growth inhibition by beta interferon exhibit aberrant platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor signal transduction.
Mundschau LJ; Faller DV
Mol Cell Biol; 1991 Jun; 11(6):3148-54. PubMed ID: 1645446
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
